The U.S. Supreme Court has decided to take up the In re Bilski case. The Court will review a decision in a patent case which questions what things are patentable, including software and business strategies. The applicants have filed a Petition for Writ of Certiorari to the Supreme Court to appeal from the U.S. Court […]
The U.S. Patent and Trademark Office (PTO) ordered the reexamination of Merck’s biggest selling product, Singulair. The challenged patent, U.S. Patent No. 5,565,473 (“Unsaturated Hydroxyalkylquinoline Acids as Leukotriene Antagonists,” issued October 15, 1996), covers montelukast sodium, the active ingredient in the $4.5 billion-a-year allergy and asthma drug. The request for reexam, No. 90/009,432, was made […]
The American Conference Institute’s 11th Advanced Forum on Biotech Patents: Comprehensive & Practical Biotech Patent Prosecution and Litigation Strategies for an Evolving Legal Climate will be held at the Royal Sonesta Hotel, Boston, MA, on September 30-October 1. At the conference, I will be on a panel discussion with Warren Woessner of Schwegman Lundberg & […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
